Literature DB >> 17589928

Selective sphincteroplasty of the papilla in cases at risk due to atypical anatomy.

F Mugica1, G Urdapilleta, A Castiella, A Berbiela, F Alzate, E Zapata, L Zubiaurre, P Lopez, J-I Arenas.   

Abstract

AIM: To analyze the indications, efficacy and safety of sphincteroplasty in our centre.
METHODS: A retrospective study of sphincteroplasty in 53 cases of papilla at high risk was performed in 2004-2006. The procedure consisted of duodenoscopy with Olympus TJF 145 Videoduodenoscope, approach to the biliary tract using a catheter with a guidewire, and dilatation of the papilla with a dilatation balloon catheter using a syringe with a manometer for control of the filling pressure.
RESULTS: The indications included intradiverticular papilla in 26 patients (49%), stenosis of a previous sphincterotomy in 19 patients (35.8%), small size of the papilla in 4 patients (7.5%), Billroth II gastrectomy in 3 patients (5.6%), and coagulopathy in one patient (1.9%). The efficacy was 97.8%, with all the calculi extracted from the common bile duct in 84.4% of the patients, even though 21 of the patients (39.6%) had calculi with a diameter equal to or greater than 10 mm. Seven patients (13.2%) presented complications: haemorrhage in 1 patient (1.9%) and mild pancreatitis in 6 patients (11.3%). The mean hospital stay in case of complications was of 3 +/- 0.63 d.
CONCLUSION: Sphincteroplasty is highly effective, with a complication rate similar to that of sphincterotomy, furthermore, the complications are of low clinical importance. The use of the 10 mm balloon makes it possible to extract calculi with a diameter of over 15 mm and to extract more than 3 calculi without increasing the rate of complications and reduces the need to resort to lithotripsy or rescue sphincterotomy.

Entities:  

Mesh:

Year:  2007        PMID: 17589928      PMCID: PMC4172619          DOI: 10.3748/wjg.v13.i22.3106

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: A prospective randomized controlled multicenter trial.

Authors:  Naotaka Fujita; Hiroyuki Maguchi; Yutaka Komatsu; Ichiro Yasuda; Osamu Hasebe; Yoshinori Igarashi; Akihiko Murakami; Hidekazu Mukai; Tsuneshi Fujii; Kenji Yamao; Kensei Maeshiro
Journal:  Gastrointest Endosc       Date:  2003-02       Impact factor: 9.427

2.  Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones.

Authors:  James A Disario; Martin L Freeman; David J Bjorkman; Padraic Macmathuna; Bret T Petersen; Philip E Jaffe; Thomas G Morales; Lee J Hixson; Stuart Sherman; Glen A Lehman; M Mazen Jamal; Firas H Al-Kawas; Mukul Khandelwal; Joseph P Moore; Gregory A Derfus; Priya A Jamidar; Francisco C Ramirez; Michael E Ryan; Karen L Woods; David L Carr-Locke; Stephen C Alder
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

3.  Randomised trial of laparoscopic exploration of common bile duct versus postoperative endoscopic retrograde cholangiography for common bile duct stones.

Authors:  M Rhodes; L Sussman; L Cohen; M P Lewis
Journal:  Lancet       Date:  1998-01-17       Impact factor: 79.321

4.  Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones.

Authors:  T Aizawa; N Ueno
Journal:  Gastrointest Endosc       Date:  2001-08       Impact factor: 9.427

5.  The acute and long-term effect of balloon sphincteroplasty on papillary structure in pigs.

Authors:  P Mac Mathuna; D Siegenberg; D Gibbons; D Gorin; M O'Brien; N A Afdhal; R Chuttani
Journal:  Gastrointest Endosc       Date:  1996-12       Impact factor: 9.427

6.  Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones.

Authors:  J J Bergman; E A Rauws; P Fockens; A M van Berkel; P M Bossuyt; J G Tijssen; G N Tytgat; K Huibregtse
Journal:  Lancet       Date:  1997-04-19       Impact factor: 79.321

7.  Major hemorrhage from endoscopic sphincterotomy: risk factor analysis.

Authors:  D B Nelson; M L Freeman
Journal:  J Clin Gastroenterol       Date:  1994-12       Impact factor: 3.062

8.  Histological analysis of the papilla after endoscopic papillary balloon dilation.

Authors:  Takao Kawabe; Yutaka Komatsu; Hiroyuki Isayama; T Takemura; Nobuo Toda; Minoru Tada; Yasuo Imai; Y Shiratori; M Omata
Journal:  Hepatogastroenterology       Date:  2003 Jul-Aug

9.  Treatment of choledocholithiasis in patients with liver cirrhosis. Surgical treatment or endoscopic sphincterotomy?

Authors:  M Sugiyama; Y Atomi; A Kuroda; T Muto
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

10.  Choledocholithiasis in cirrhotic patients: is endoscopic sphincterotomy the safest choice?

Authors:  V F Moreira; R Arribas; A L Sanroman; E Meroño; C Larena; M Garcia; G Torres
Journal:  Am J Gastroenterol       Date:  1991-08       Impact factor: 10.864

View more
  4 in total

1.  Endoscopic removal of a bile-duct stone using sphincterotomy and a large-balloon dilator in a patient with situs inversus totalis.

Authors:  Jin Ho Lee; Dae Hwan Kang; Jong Hwan Park; Min Dae Kim; Ki Tae Yoon; Cheol Woong Choi; Hyung Wook Kim; Mong Cho
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

2.  Sphincter of Oddi laxity: an important factor in hepatolithiasis.

Authors:  Ting-Bo Liang; Yu Liu; Xue-Li Bai; Jun Yu; Wei Chen
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

3.  Endoscopic papillary balloon dilation for difficult common bile duct stones: Our experience.

Authors:  Maddalena Zippi; Isabella De Felici; Roberta Pica; Giampiero Traversa; Giuseppe Occhigrossi
Journal:  World J Clin Cases       Date:  2013-04-16       Impact factor: 1.337

4.  Sequential endoscopic papillary balloon dilatation following limited sphincterotomy for common bile duct stones.

Authors:  Rakesh Kochhar; Usha Dutta; Rajat Shukla; Birinder Nagi; Kartar Singh; Jai D Wig
Journal:  Dig Dis Sci       Date:  2008-11-13       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.